ArticleFrontiers in pharmacology2023

A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice.

Jade Gauvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.